8-K - Lyell Immunopharma, Inc. | StockGist

Current Report Details

Event Type

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 3, 2025, the Board of Directors (the “Board”) of Lyell Immunopharma, Inc.

Charter Amendment

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 3.1 Amended and Restated Bylaws of Lyell Immunopharma, Inc. 104 Cover Page Interactiv

Exhibits Only

Exhibits (2)

3.1

EX-3.1

8-K